|Bid||0.00 x 1200|
|Ask||35.78 x 900|
|Day's range||31.30 - 31.61|
|52-week range||26.51 - 37.37|
|Beta (5Y monthly)||1.33|
|PE ratio (TTM)||18.38|
|Earnings date||21 Jun 2022 - 27 Jun 2022|
|Forward dividend & yield||1.04 (3.32%)|
|Ex-dividend date||21 Apr 2022|
|1y target est||35.64|
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
Catalent's (CTLT) latest launch is expected to provide a reliable, reproducible and scalable path to clinic to its customers.
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.